Ignyta: Precision Medicine for Oncology Integrating Companion Diagnostics
Teva Deal Expands Portfolio and Diagnostic Capabilities Adding RXDX to Rayno Small Cap Portfolio Ignyta, Inc. (RXDX) is an emerging biopharmaceutical Company targeting new oncology drugs that inhibit Tyrosine kinase receptors (Trk) with integrated biomarker-based companion diagnostics for each...
Sierra SnowBlog: A Little Relief Next Week 4/5, Drought… Update-1 4/7
Update -2 The Coot Indicator Look for coots (crane relative) on Little Lake at US 395 South of Lone Pine. Two weeks ago during a warming trend the coots were still there indicating winter was still on. The coots head out of the Eastern Sierras in the Spring. This a Winter Storm arrived. The...
Risk-Off for Biotech Trades… Update-2
4/1…at close ETF summary FBT at $116.87 down 1.15%, early support at $115. IBB at $340 touching bottom of upward channel, down 1%. XBI at $220.50 down 2.22%. At technical support. ETF leader with equal weight holdings in small and mid-caps. Another weak day for large caps ALXN, AMGN,...
Snap-Back Rally In Biotech-But Lagging Other Sectors
Global Rally Today But Healthcare Sector Lags A Bit DOW up 1.49% at 17,976 NASDAQ Up 1.15% at 4947 Healthcare up 0.93% We are in Day Two of the biotech rally that was sparked last Friday with the rumor supported by a Deutsche Bank analyst that Biomarin (BMRN) was a takeover target. The Company...
Risk Off For Biotech Trades-BIIB, GILD, XBI…Update-2
Update 3/25 Mid-Day Trading NAZ Off 1.55% at 4917 “Bubble Talk” Picking Up-Mid Caps Vulnerable Biotech sector selling picked up today with a dramatic shift in sentiment exacerbated by an overall weak market. Also durable goods fell unexpectedly 1.4% in February indicating weak...